Abivax (AAVXF) Short term Debt (2021 - 2025)

Abivax has reported Short term Debt for 5 years, with the latest figure at $32.8 million in Q3 2025.

• On a quarterly basis, Short term Debt changed N/A year-over-year to $32.8 million in Q3 2025; TTM through Sep 2025 was $32.8 million, a N/A change from a year earlier, with the FY2023 full-year figure at $3.5 million, up 5.46% from the prior year.
• Short term Debt was $32.8 million for Q3 2025 at Abivax, down from $57.1 million in the prior quarter.
• The five-year high for Short term Debt was $57.1 million in Q2 2025, with the low at $3.3 million in Q4 2022.
• Average Short term Debt over 5 years is $24.8 million, with a median of $19.7 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2025: Short term Debt tumbled 48.59% in 2022, then gained 25.46% in 2025.
• Over 5 years, Short term Debt stood at $6.5 million in 2021, then sank by 48.59% to $3.3 million in 2022, then rose by 5.46% to $3.5 million in 2023, then jumped by 1195.65% to $45.5 million in 2024, then decreased by 27.76% to $32.8 million in 2025.
• The last three Short term Debt figures came in at $32.8 million (Q3 2025), $57.1 million (Q2 2025), and $45.5 million (Q2 2024), per Business Quant data.